These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 23970349)
21. Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma. Yang MH; Chen CL; Chau GY; Chiou SH; Su CW; Chou TY; Peng WL; Wu JC Hepatology; 2009 Nov; 50(5):1464-74. PubMed ID: 19821482 [TBL] [Abstract][Full Text] [Related]
22. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling. Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771 [TBL] [Abstract][Full Text] [Related]
23. Hypoxia promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells via inducing Twist1 expression. Zhang XD; Dong XQ; Xu JL; Chen SC; Sun Z Eur Rev Med Pharmacol Sci; 2017 Jul; 21(13):3061-3068. PubMed ID: 28742200 [TBL] [Abstract][Full Text] [Related]
24. A20 suppresses hepatocellular carcinoma proliferation and metastasis through inhibition of Twist1 expression. Chen H; Hu L; Luo Z; Zhang J; Zhang C; Qiu B; Dong L; Tan Y; Ding J; Tang S; Shen F; Li Z; Wang H Mol Cancer; 2015 Nov; 14():186. PubMed ID: 26538215 [TBL] [Abstract][Full Text] [Related]
25. Anti-Cancer Effects of Glaucarubinone in the Hepatocellular Carcinoma Cell Line Huh7 via Regulation of the Epithelial-To-Mesenchymal Transition-Associated Transcription Factor Twist1. Seo J; Ha J; Kang E; Yoon H; Lee S; Ryu SY; Kim K; Cho S Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33567682 [TBL] [Abstract][Full Text] [Related]
26. Hypoxia induced epithelial-mesenchymal transition and vasculogenic mimicry formation by promoting Bcl-2/Twist1 cooperation. Liu K; Sun B; Zhao X; Wang X; Li Y; Qiu Z; Gu Q; Dong X; Zhang Y; Wang Y; Zhao N Exp Mol Pathol; 2015 Oct; 99(2):383-91. PubMed ID: 26318343 [TBL] [Abstract][Full Text] [Related]
27. Systems approach to characterize the metabolism of liver cancer stem cells expressing CD133. Hur W; Ryu JY; Kim HU; Hong SW; Lee EB; Lee SY; Yoon SK Sci Rep; 2017 Apr; 7():45557. PubMed ID: 28367990 [TBL] [Abstract][Full Text] [Related]
28. Growth differentiation factor 15 induces growth and metastasis of human liver cancer stem-like cells via AKT/GSK-3β/β-catenin signaling. Xu Q; Xu HX; Li JP; Wang S; Fu Z; Jia J; Wang L; Zhu ZF; Lu R; Yao Z Oncotarget; 2017 Mar; 8(10):16972-16987. PubMed ID: 28199981 [TBL] [Abstract][Full Text] [Related]
29. Casticin inhibits epithelial-mesenchymal transition of liver cancer stem cells of the SMMC-7721 cell line through downregulating Twist. He M; Cao XC; He GC; Sheng XF; Ai XH; Wu YH Oncol Lett; 2014 May; 7(5):1625-1631. PubMed ID: 24765190 [TBL] [Abstract][Full Text] [Related]
30. Liver cancer stem cell dissemination and metastasis: uncovering the role of NRCAM in hepatocellular carcinoma. Zhou L; He L; Liu CH; Qiu H; Zheng L; Sample KM; Wu Q; Li J; Xie K; Ampuero J; Li Z; Lv D; Liu M; Romero-Gómez M; Hu Y; Tang H J Exp Clin Cancer Res; 2023 Nov; 42(1):311. PubMed ID: 37993901 [TBL] [Abstract][Full Text] [Related]
31. STAT3 cooperates with Twist to mediate epithelial-mesenchymal transition in human hepatocellular carcinoma cells. Zhang C; Guo F; Xu G; Ma J; Shao F Oncol Rep; 2015 Apr; 33(4):1872-82. PubMed ID: 25653024 [TBL] [Abstract][Full Text] [Related]
32. L1-mediated colon cancer cell metastasis does not require changes in EMT and cancer stem cell markers. Gavert N; Vivanti A; Hazin J; Brabletz T; Ben-Ze'ev A Mol Cancer Res; 2011 Jan; 9(1):14-24. PubMed ID: 21123622 [TBL] [Abstract][Full Text] [Related]
33. SND1 affects proliferation of hepatocellular carcinoma cell line SMMC-7721 by regulating IGFBP3 expression. Yin J; Ding J; Huang L; Tian X; Shi X; Zhi L; Song J; Zhang Y; Gao X; Yao Z; Jing X; Yang J Anat Rec (Hoboken); 2013 Oct; 296(10):1568-75. PubMed ID: 23878061 [TBL] [Abstract][Full Text] [Related]
34. Inhibition of the cancer stem cells-like properties by arsenic trioxide, involved in the attenuation of endogenous transforming growth factor beta signal. Li Y; Jiang F; Liu Q; Shen J; Wang X; Li Z; Zhang J; Lu X Toxicol Sci; 2015 Jan; 143(1):156-64. PubMed ID: 25304214 [TBL] [Abstract][Full Text] [Related]
35. 8-Bromo-7-methoxychrysin-induced apoptosis of hepatocellular carcinoma cells involves ROS and JNK. Yang XH; Zheng X; Cao JG; Xiang HL; Liu F; Lv Y World J Gastroenterol; 2010 Jul; 16(27):3385-93. PubMed ID: 20632440 [TBL] [Abstract][Full Text] [Related]
36. Autophagy contributes to the survival of CD133+ liver cancer stem cells in the hypoxic and nutrient-deprived tumor microenvironment. Song YJ; Zhang SS; Guo XL; Sun K; Han ZP; Li R; Zhao QD; Deng WJ; Xie XQ; Zhang JW; Wu MC; Wei LX Cancer Lett; 2013 Oct; 339(1):70-81. PubMed ID: 23879969 [TBL] [Abstract][Full Text] [Related]
37. Rap1b enhances the invasion and migration of hepatocellular carcinoma cells by up-regulating Twist 1. Tang Z; Peng H; Chen J; Liu Y; Yan S; Yu G; Chen Q; Tang H; Liu S Exp Cell Res; 2018 Jun; 367(1):56-64. PubMed ID: 29559227 [TBL] [Abstract][Full Text] [Related]
38. Peroxiredoxin II Is Essential for Maintaining Stemness by Redox Regulation in Liver Cancer Cells. Kwon T; Bak Y; Park YH; Jang GB; Nam JS; Yoo JE; Park YN; Bak IS; Kim JM; Yoon DY; Yu DY Stem Cells; 2016 May; 34(5):1188-97. PubMed ID: 26866938 [TBL] [Abstract][Full Text] [Related]
39. TLR4 Signaling via NANOG Cooperates With STAT3 to Activate Twist1 and Promote Formation of Tumor-Initiating Stem-Like Cells in Livers of Mice. Uthaya Kumar DB; Chen CL; Liu JC; Feldman DE; Sher LS; French S; DiNorcia J; French SW; Naini BV; Junrungsee S; Agopian VG; Zarrinpar A; Machida K Gastroenterology; 2016 Mar; 150(3):707-19. PubMed ID: 26582088 [TBL] [Abstract][Full Text] [Related]
40. Musashi2 contributes to the maintenance of CD44v6+ liver cancer stem cells via notch1 signaling pathway. Wang X; Wang R; Bai S; Xiong S; Li Y; Liu M; Zhao Z; Wang Y; Zhao Y; Chen W; Billiar TR; Cheng B J Exp Clin Cancer Res; 2019 Dec; 38(1):505. PubMed ID: 31888685 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]